pmdd
(2)
Aavia
Aavia is a hormone health company building a daily app that helps people with ovaries understand how their ovarian hormones shape their energy, mood, sleep, skin, and sex drive across the cycle. Founded at MIT in 2017, it began with a patented Smart Birth Control Pill Case that senses whether you have taken your pill and reminds you until you do, then grew into an all-in-one tracking and education platform with personalized, science-backed insights, a member community, and a medical advisory board.
Samphire Neuroscience
Samphire Neuroscience is a London-based neurotechnology company building drug-free, hormone-free wearables for women's health. Its flagship product, Nettle, is a headband that uses transcranial direct current stimulation (tDCS) to gently modulate the brain regions tied to mood and pain, worn 20 minutes a day in the run-up to menstruation. Marketed as the first EU-cleared (CE-certified) neuromodulation device for women's health, Nettle targets PMS, PMDD, menstrual pain and related hormonal conditions. Founded in 2021 by neuroscientist Emilė Radytė and IP lawyer Alex Cook, the company has raised roughly $7.77M across pre-seed, seed and Series A rounds.